McConnell Plugs 'Cures' To Address Regenerative Medicine As FDA Regs Criticized

Senate Majority Leader Mitch McConnell (R-KY) cited regenerative medicine as a reason he is interested in getting 21st Century Cures Act passed in the lame duck session, coming as stakeholders remain divided on how to revamp FDA's current regulatory approach under which certain cell and tissue products go through rigorous premarket approval while others do not, creating what some say is unfair competition. Senate health committee Chairman Lamar Alexander (R-TN) previously said legislation aimed at streamlining the development of cellular...